rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524804 AUROPHARMA Group (A)

Aurobindo Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
1153.00   17.45   1.54%
Volume 29,895
Prev close 1,135.55
Day's H/L (Rs.) 1,159.85 - 1,141.00
52wk H/L (Rs.) 1,279.05 - 504.50
Mkt Cap (Rs. Cr) 33,667.60
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

AUROPHARMA

Aurobindo Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
1154.45   19.70   1.74%
Volume 436,073
Prev close 1134.75
Day's H/L (Rs.) 1,161.35 - 1,142.00
52wk H/L (Rs.) 1,279.80 - 503.40
Turnover (Rs. Lacs) 5,020.33
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Aurobindo Pharma Ltd.  (See all 2,498 market voices)   

140 Characters
  Cancel
Ashutosh - 22 hour(s) ago [SKB] [SKB] [SKB] [SKB] [SKB] To know the multibagger stock list for investment visit http://rediff.ly/3tza1 and register
#Aurobindo-Pharma-Ltd
Reply   |   Share
Ashutosh - 22 hour(s) ago [SKB] [SKB] [SKB] [SKB] [SKB] To know the multibagger stock list for investment visit http://rediff.ly/3tza1 and register
#Aurobindo-Pharma-Ltd
Reply   |   Share

Realtime news for Aurobindo Pharma Ltd. (See all 750 news)

27 March 2015, 10:43
Aurobindo Pharma appoints director - 1 day(s) ago
3/22/15 - India,United States : AUROBINDO PHARMA gets FDA approval for LACOSAMIDE TABLETS [TendersInfo (India)] - 4 day(s) ago
Aurobindo Pharma hits record high on USFDA tentative nod for Lacosamide tablets - 19 Mar 2015
AUROBINDO PHARMA : Patent Issued for Process for the Preparation of Valsartan - 1 day(s) ago
Aurobindo Pharma: Regaining traction - 17 Mar 2015

BSE Announcements from Aurobindo Pharma Ltd. (See all)

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 - 1 day(s) ago
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 - 1 day(s) ago

Company details for Aurobindo Pharma Ltd.

Report Card

PE Ratios
29.34
EPS (Rs.)
40.21
Sales (Rs. Cr)
2,097.99
Face Value (Rs.)
1
Net Profit
Margin (%)
 
16.31
Last Bonus
1:1
Last Dividend(%)
200
Return on
Average Equity
 
29.21

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Aurobindo Pharma Ltd. with other stocks

Sanofi India Ltd.
3,282.10
Glenmark Pharmaceuticals Ltd.
805.70
Show more companies
Sanofi India Ltd.
3,282.10
Glenmark Pharmaceuticals Ltd.
805.70
Torrent Pharmaceuticals Ltd.
1,148.40
Piramal Enterprises Ltd.
860.35
Apollo Hospitals Enterprise Ltd.
1,421.40
Cadila Healthcare Ltd.
1,702.60
Biocon Ltd.
434.00
GlaxoSmithKline Pharmaceuticals Ltd.
3,274.20
Sun Pharmaceutical Industries Ltd.
1,053.30
Alembic Pharmaceuticals Ltd.
447.30
Show less companies
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close